You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 13, April 7, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Omission of Financial Disclosure Information

JAMA. 1999;281:1174.

In the Original Contribution entitled "Sexual Dysfunction in the United States: Prevalence and Predictors," published in the February 10, 1999, issue of THE JOURNAL (1999;281:537-544), the financial disclosures of the authors were inadvertently omitted. Dr Edward O. Laumann has served on the Scientific Advisory Committee to Pfizer Inc, New York, NY, in the development of Viagra, a medication for erectile dysfunction, since January 1997. Dr Rosen has received research and consulting support from Pfizer Inc, Merck & Co Inc, West Point, Pa; Eli Lilly Co, Indianapolis, Ind; Bristol-Meyers Squibb Co, Princeton, NJ; Procter & Gamble, Cincinnati, Ohio; and ICOS Corp, Bothell, Wash.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.